By: Judy McMeekin, Pharm. D., Associate Commissioner for Regulatory Affairs
The FDA continues to use all tools and flexibilities available to us as we partner with federal, state, and local agencies and public health officials across the country, to combat COVID-19. A critical part of the FDA’s work is ensuring the safety and security of the U.S. supply of food and medical products.
Many of the medical products our health care workers and hospitals need to battle COVID-19 come from overseas, which makes the FDA’s Office of Regulatory Affairs (ORA) work imperative to ensure products are moving as quickly as possible through the ports of entry.
No hay comentarios:
Publicar un comentario